26 results
DRS
MAIA
MAIA Biotechnology Inc
1 Jun 23
Draft registration statement
12:00am
disagree with our efficacy interpretation of our drug; or
the FDA or comparable foreign regulatory authorities may regard our CMC package as inadequate … and send drafts of an assessment report, summary of product characteristics and the labelling and package leaflet within 120 days after receipt
8-K
EX-1.1
MAIA
MAIA Biotechnology Inc
27 Apr 23
MAIA Biotechnology, Inc. Announces Pricing of Public Offering
5:25pm
Writing Prospectus.
“Pricing Disclosure Package” means any Issuer General Use Free Writing Prospectus issued at or prior to the Applicable Time … , the Pricing Disclosure Package and the Prospectus.
2.3No Stop Orders, etc. Neither the Commission nor, to the Company’s knowledge, any state
424B4
u5kxk
25 Apr 23
Prospectus supplement with pricing info
7:45pm
DRS
xseqq j9j94
23 Dec 22
Draft registration statement
12:00am
8-K
EX-1.1
zilf70f0yt
1 Aug 22
MAIA Biotechnology Announces Pricing of Initial Public Offering
4:05pm
424B4
d67y9i 29bzyft62hdha
29 Jul 22
Prospectus supplement with pricing info
8:31am